Fresenius Medical Care AG Return on Equity (ROE) Growth & History (FME)
Fresenius Medical Care AG's return on equity was 8.54% for fiscal 2025.
View full Fresenius Medical Care AG company overviewFresenius Medical Care AG annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 8.54% | +3.29 pp |
| 2024 | 2024-12-31 | 5.25% | −0.05 pp |
| 2023 | 2023-12-31 | 5.31% | −1.40 pp |
| 2022 | 2022-12-31 | 6.70% | −3.49 pp |
| 2021 | 2021-12-31 | 10.20% | −2.20 pp |
| 2020 | 2020-12-31 | 12.39% | +0.26 pp |
| 2019 | 2019-12-31 | 12.13% | −8.50 pp |
| 2018 | 2018-12-31 | 20.63% | +4.92 pp |
| 2017 | 2017-12-31 | 15.70% | +1.35 pp |
| 2016 | 2016-12-31 | 14.36% | +0.43 pp |
| 2015 | 2015-12-31 | 13.92% | +0.62 pp |
| 2014 | 2014-12-31 | 13.30% | +1.45 pp |
| 2013 | 2013-12-31 | 11.85% | −3.90 pp |
| 2012 | 2012-12-31 | 15.76% | +0.35 pp |
| 2011 | 2011-12-31 | 15.41% | — |
Fresenius Medical Care AG quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 1.69% | −0.28 pp |
| Q1 2026 | 2026-03-31 | 0.89% | −0.42 pp |
| Q4 2025 | 2025-12-31 | 3.06% | +2.22 pp |
| Q3 2025 | 2025-09-30 | 2.50% | +0.58 pp |
| Q2 2025 | 2025-06-30 | 1.97% | +0.24 pp |
| Q1 2025 | 2025-03-31 | 1.31% | +0.45 pp |
| Q4 2024 | 2024-12-31 | 0.84% | −1.02 pp |
| Q3 2024 | 2024-09-30 | 1.92% | +0.85 pp |
| Q2 2024 | 2024-06-30 | 1.73% | +0.30 pp |
| Q1 2024 | 2024-03-31 | 0.86% | −0.10 pp |
| Q4 2023 | 2023-12-31 | 1.86% | +0.52 pp |
| Q3 2023 | 2023-09-30 | 1.07% | −0.88 pp |
| Q2 2023 | 2023-06-30 | 1.43% | −0.08 pp |
| Q1 2023 | 2023-03-31 | 0.96% | −0.67 pp |
| Q4 2022 | 2022-12-31 | 1.33% | −1.10 pp |
| Q3 2022 | 2022-09-30 | 1.94% | −0.83 pp |
| Q2 2022 | 2022-06-30 | 1.51% | −0.86 pp |
| Q1 2022 | 2022-03-31 | 1.63% | −0.99 pp |
| Q4 2021 | 2021-12-31 | 2.44% | +0.33 pp |
| Q3 2021 | 2021-09-30 | 2.78% | −0.78 pp |
| Q2 2021 | 2021-06-30 | 2.37% | −1.17 pp |
| Q1 2021 | 2021-03-31 | 2.62% | −0.30 pp |
| Q4 2020 | 2020-12-31 | 2.10% | −1.24 pp |
| Q3 2020 | 2020-09-30 | 3.55% | +0.28 pp |
| Q2 2020 | 2020-06-30 | 3.54% | +0.88 pp |
| Q1 2020 | 2020-03-31 | 2.93% | +0.17 pp |
| Q4 2019 | 2019-12-31 | 3.34% | −0.95 pp |
| Q3 2019 | 2019-09-30 | 3.28% | +0.13 pp |
| Q2 2019 | 2019-06-30 | 2.66% | −7.47 pp |
| Q1 2019 | 2019-03-31 | 2.75% | −0.59 pp |
| Q4 2018 | 2018-12-31 | 4.28% | −0.45 pp |
| Q3 2018 | 2018-09-30 | 3.15% | — |
| Q2 2018 | 2018-06-30 | 10.13% | — |
| Q1 2018 | 2018-03-31 | 3.34% | — |
| Q4 2017 | 2017-12-31 | 4.74% | — |
Fresenius Medical Care AG return on equity trends
Over the last five fiscal years, Fresenius Medical Care AG's return on equity decreased from 12.39% to 8.54%, a change of −3.85 percentage points. The latest reported quarter, Q2 2026, shows 1.69%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Fresenius Medical Care AG source filings ↗